AU2003212888A1 - Combinations for the treatment of fungal infections - Google Patents

Combinations for the treatment of fungal infections

Info

Publication number
AU2003212888A1
AU2003212888A1 AU2003212888A AU2003212888A AU2003212888A1 AU 2003212888 A1 AU2003212888 A1 AU 2003212888A1 AU 2003212888 A AU2003212888 A AU 2003212888A AU 2003212888 A AU2003212888 A AU 2003212888A AU 2003212888 A1 AU2003212888 A1 AU 2003212888A1
Authority
AU
Australia
Prior art keywords
combinations
treatment
fungal infections
fungal
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212888A
Other languages
English (en)
Inventor
Benjamin A. Auspitz
Curtis Keith
M. James Nichols
George N. Serbedzija
Grant R. Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zalicus Inc
Original Assignee
CombinatoRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CombinatoRx Inc filed Critical CombinatoRx Inc
Publication of AU2003212888A1 publication Critical patent/AU2003212888A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003212888A 2002-02-06 2003-01-31 Combinations for the treatment of fungal infections Abandoned AU2003212888A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35464502P 2002-02-06 2002-02-06
US60/354,645 2002-02-06
PCT/US2003/003039 WO2003066049A1 (fr) 2002-02-06 2003-01-31 Combinaisons pour le traitement des infections fongiques

Publications (1)

Publication Number Publication Date
AU2003212888A1 true AU2003212888A1 (en) 2003-09-02

Family

ID=27734403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212888A Abandoned AU2003212888A1 (en) 2002-02-06 2003-01-31 Combinations for the treatment of fungal infections

Country Status (2)

Country Link
AU (1) AU2003212888A1 (fr)
WO (1) WO2003066049A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863273B1 (fr) * 2003-12-03 2008-02-08 Univ Nantes Milieu, dispositif et procede de test de la sensibilite d'un inoculum de champignons a un agent antifongique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817321A (en) * 1992-10-08 1998-10-06 Supratek Pharma, Inc. Biological agent compositions

Also Published As

Publication number Publication date
WO2003066049A1 (fr) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2003268348A1 (en) Secure network-routed voice processing
AU2003211453A1 (en) External compositions for the skin
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003233357A1 (en) Dressing aid
AU2003903242A0 (en) Process for the treatment of wood
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2003233820A1 (en) Method for the treatment of starch
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
AU2003223538A1 (en) Methods for the treatment of cancer
AU2002353510A1 (en) Nebuliser
AU2003258983A1 (en) Combinations for the treatment of fungal infections
AU2003206367A1 (en) Technical field of the invention
AU2002354472A1 (en) Combine
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2003301012A1 (en) Use of beta-defensins for treating hiv infections
AU2002355026A1 (en) Combine
AUPR963401A0 (en) Methods for the enhancement of complex peaks
AU2001258675A1 (en) Treating infections
AU2003212888A1 (en) Combinations for the treatment of fungal infections
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003218718A1 (en) Utilization of ubiquinones for influencing the effect of histamine
AU2003226628A1 (en) METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER
AU2003211274A1 (en) Remedy for infections
AU2003281158A1 (en) The treatment of emesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase